Belgio - inglese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium sa-nv - rabies virus (inactivated) >= 2 iu/dose - suspension for injection - rabies virus, inactivated - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira - cattle; dog; goat; horse; cat; sheep; other species or species not known; pig

Armenia - inglese - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

serum institute of india pvt ltd. - purified rabies antigen - powder lyophilized for solution for injection and solvent - 2,5iu/ml

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - rabies vaccine, wistar pm/wi 38-1503-3m 3.25 [iu] (target quantity per dose) - powder for injection with diluent - 3.25 iu - active: rabies vaccine, wistar pm/wi 38-1503-3m 3.25 [iu] (target quantity per dose) excipient: albumin hydrochloric acid bme medium - mineral salts, vitamins, amino acids including l-phenylalanine maltose sodium hydroxide sodium chloride water for injection - verorab is indicated for pre-exposure and post-exposure prophylaxis against rabies in all age groups. verorab should be used in accordance with official local recommendations. generally, pre-exposure prophylaxis should be offered to people at high risk of exposure such as those working in rabies diagnostic or research laboratories, veterinarians, animal handlers potentially exposed to rabid animals, as well as other people (especially children) living in or traveling to high-risk areas.

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - inactivated rabies virus, strain vnukovo-32 - suspension for injection - unknown - rabies virus vaccine - bovine, canine, caprine, equine - food, feline, ferret, ovine, porcine - immunological - inactivated vaccine

Unione Europea - inglese - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - vcp65 virus - immunologicals - cats - active immunisation of cats 12 weeks of age and older to prevent mortality due to rabies infection.onset of immunity: 4 weeks after the primary vaccination course.duration of immunity after primary vaccination: 1 year.duration of immunity after revaccination: 3 years.

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

intervet ireland limited - inactivated rabies virus antigen suspension - suspension for injection - 2-6 international units/dose - rabies virus - cats, dogs - immunological - inactivated vaccine

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - rabies vaccine 2.5 [iu] - injection with diluent - 2.5 iu - active: rabies vaccine 2.5 [iu] excipient: disodium edetate potassium l-glutamate polygeline sodium chloride sucrose trometamol water for injection - active immunisation against rabies virus, including (a) pre-exposure immunisation, (b) post-exposure treatment following exposure to rabies virus

India - inglese - Central Drugs Standard Control Organization

gen bio. - rabies immunoglobulin - vaccine - anti rabies serum - single dose via syringe diluent

India - inglese - Central Drugs Standard Control Organization

ranbaxy - rabies immunoglobulin - 300iu. (human rabies ig 300iu.) - 2ml

Australia - inglese - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - rabies virus -